| Literature DB >> 35515974 |
Mithat Eksi1, Deniz Noyan Ozlu2, Taner Kargi2, Abdullah Hizir Yavuzsan3, Ahmet Haciislamoglu2, Serdar Karadag2, Selcuk Sahin2, Ali Ihsan Tasci2.
Abstract
Objectives: Percutaneous nephrolithotomy (PNL) for upper urinary tract stones is a minimally invasive, effective treatment modality. Despite its high success rates, its potential complications pose a risk. In this study, we aimed to determine the risk factors associated with bleeding which is one of PNL's most important complications.Entities:
Keywords: Hemorrhage; kidney calculi; percutaneous nephrolithotomy
Year: 2022 PMID: 35515974 PMCID: PMC9040304 DOI: 10.14744/SEMB.2021.21284
Source DB: PubMed Journal: Sisli Etfal Hastan Tip Bul ISSN: 1302-7123
Patients demographics, peroperative, and post-operative datas
|
|
| |||
|---|---|---|---|---|
| Decrease in Hg (g/dl) | 1.9±0.6 | 2.8±1.2 | 0.8±0.4 | 0.001 |
| Age (year) | 39.7±11.5 | 47.4±7.9 | 32±9.4 | 0.000 |
| Gender (m/f) (n; %) | 130/39 (76.9/23.1) | 64/21 (75.3/24.7) | 66/18 (78.6/21.4) | 0.374+ |
| Comorbidities | ||||
| DM (n; %) | 22 ( | 9 (10.5) | 13 (15.4) | 0.370 |
| HT (n; %) | 22 ( | 16 (18.8) | 6 (7.1) | 0.038 |
| BMI (kg/m2) | 27.4±3.1 | 27.2±2.8 | 27.5±3.4 | 0.584 |
| Operation time (min) | 80.2±10 | 84.4±7 | 76.2±9.9 | 0.000 |
| LOS (day) | 3.6±1.5 | 3.7±1.7 | 3.4±1.3 | 0.217 |
| Complication (n; %) | 37 (21.8) | 25 (29.4) | 12 (14.2) | 0.019+ |
| Clavien 1 | 9 (5.3) | 4 (4.7) | 5 (5.9) | |
| Clavien 2 | 16 (9.46) | 13 (15.2) | 3 (3.5) | |
| Clavien 3a | 9 (5.3) | 6 ( | 3 (3.5) | |
| Clavien 3b | 3 (1.7) | 2 (2.3) | 1 (1.1) | |
| ERT (n; %) | 11 (6.5) | 11 (12.9) | 0 (0) | 0.001+ |
| SFR (n; %) | 136 (80.4) | 66 (77.6) | 70 (83.3) | 0.351 |
SD: Standard deviation; Hg: Hemoglobin; DM: Diabetes mellitus; HT: Hypertension; BMI: Body mass index; LOS: Length of stay; ERT: Erythrocyte replacement therapy; SFR: Stone free rate.
Stone characteristics
|
| ||||
|---|---|---|---|---|
| Laterality (n; %) | ||||
| Left | 69 (40.8) | 33 (38.8) | 36 (42.9) | 0.353+ |
| Right | 100 (59.2) | 52 (61.2) | 48 (57.1) | |
| Stone Burden (mean±SD) | 2530.9±1067.9 | 2733±1121.3 | 2326.5±975.6 | 0.013 |
| HU (mean±SD) | 979.8±319.3 | 999.1±332.2 | 960.2±306.5 | 0.431 |
| Hydronephrosis (n; %) | ||||
| 0 | 18 (10.7) | 8 (9.4) | 10 (11.9) | 0.234+ |
| 1 | 61 (36.1) | 31 (36.5) | 30 (35.7) | |
| 2 | 67 (39.6) | 34 (40) | 33 (39.3) | |
| 3 | 19 (11.2) | 12 (14.1) | 7 (8.3) | |
| 4 | 4 (2.4) | - | 4 (4.8) | |
| S.T.O.N.E | 7.4±1.6 | 7.64±1.6 | 7.2±1.6 | 0.153 |
| CROES | 196.4±62.6 | 190.5±64.1 | 202.4±60.8 | 0.216 |
| GUY’S | ||||
| 1 | 55 (32.5) | 28 | 27 | 0.556+ |
| 2 | 69 (40.8) | 31 | 38 | |
| 3 | 24 (14.2) | 13 | 11 | |
| 4 | 21 (12.4) | 13 | 8 |
SD: Standard deviation; HU: Hounsfield Unit; CROES: Clinical Research Office of the Endourological Society.
Univariate and multivariate analysis to determine the predictors of hemoglobin decrease
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Age | 0.841 | 0.801–0.883 | 0.000 | 0.840 | 0.799–0.882 | 0.000 |
| Hypertension | 3.014 | 1.117–8.134 | 0.029 | 3.781 | 1.168–12.247 | 0.027 |
| Stone Burden | 1.000 | 0.999–1.000 | 0.015 | 1.000 | 0.999–1.000 | 0.234 |
CI: Confidence interval.
Figure 1.Receiver operating characteristic curve analysis of predictors of hemoglobin decrease.